Diana Lake

2.6k total citations
70 papers, 1.7k citations indexed

About

Diana Lake is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Diana Lake has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 26 papers in Cancer Research and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Diana Lake's work include Cancer Treatment and Pharmacology (36 papers), HER2/EGFR in Cancer Research (34 papers) and Breast Cancer Treatment Studies (23 papers). Diana Lake is often cited by papers focused on Cancer Treatment and Pharmacology (36 papers), HER2/EGFR in Cancer Research (34 papers) and Breast Cancer Treatment Studies (23 papers). Diana Lake collaborates with scholars based in United States, Canada and Palestinian Territory. Diana Lake's co-authors include Clifford A. Hudis, Larry Norton, Andrew D. Seidman, Eric P. Winer, Constance Cirrincione, Harold J. Burstein, Donald A. Berry, Hyman B. Muss, Peter C. Ungaro and P. Kelly Marcom and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Diana Lake

66 papers receiving 1.7k citations

Peers

Diana Lake
А. Н. Махсон Russia
Günther Steger Austria
A. Antón Spain
Evangelia Razis Greece
Hans‐Joachim Lück Germany
Thomas E. Seay United States
James D. Reimann United States
D. Fennelly Ireland
Vicente Guillém Spain
Giovanna Masci Italy
А. Н. Махсон Russia
Diana Lake
Citations per year, relative to Diana Lake Diana Lake (= 1×) peers А. Н. Махсон

Countries citing papers authored by Diana Lake

Since Specialization
Citations

This map shows the geographic impact of Diana Lake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Lake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Lake more than expected).

Fields of papers citing papers by Diana Lake

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Lake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Lake. The network helps show where Diana Lake may publish in the future.

Co-authorship network of co-authors of Diana Lake

This figure shows the co-authorship network connecting the top 25 collaborators of Diana Lake. A scholar is included among the top collaborators of Diana Lake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Lake. Diana Lake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reingold, Rachel, Alexander Pan, Lukas Kraehenbuehl, et al.. (2024). Oral minoxidil for late alopecia in cancer survivors. Breast Cancer Research and Treatment. 208(3). 491–499. 8 indexed citations
2.
Dusza, Stephen W., Elizabeth Quigley, Alina Markova, et al.. (2023). Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients. Breast Cancer Research and Treatment. 203(2). 271–280. 2 indexed citations
3.
Lake, Diana & Andrew D. Seidman. (2019). Adjuvant chemotherapy for node negative, high Recurrence ScoreTM breast cancer: in defense of de-escalation. npj Breast Cancer. 5(1). 24–24.
4.
5.
Ulaner, Gary A., Serge K. Lyashchenko, Christopher C. Riedl, et al.. (2017). First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using 89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer. Journal of Nuclear Medicine. 59(6). 900–906. 141 indexed citations
6.
Iyengar, Neil M., Lillian M. Smyth, Diana Lake, et al.. (2016). Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapy. Annals of Oncology. 27. vi84–vi84. 2 indexed citations
7.
Iyengar, Neil M., Monica Fornier, Steven Sugarman, et al.. (2015). A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer. Clinical Breast Cancer. 16(2). 87–94. 2 indexed citations
8.
Jochelson, Maxine S., et al.. (2015). Do MRI and Mammography Reliably Identify Candidates for Breast Conservation After Neoadjuvant Chemotherapy?. Annals of Surgical Oncology. 22(5). 1490–1495. 20 indexed citations
9.
Dang, Chau T., Neil M. Iyengar, Gabriella D’Andrea, et al.. (2014). Phase II Study of Paclitaxel Given Once per Week Along With Trastuzumab and Pertuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Journal of Clinical Oncology. 33(5). 442–447. 55 indexed citations
10.
Fozard, J. B. J., et al.. (2011). Periorbital cellulits – a mistaken diagnosis!. BMJ Case Reports. 2011. bcr0720114508–bcr0720114508. 4 indexed citations
11.
12.
Dang, Chau T., Gabriella D’Andrea, Diana Lake, et al.. (2008). Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible. Clinical Breast Cancer. 8(5). 418–424. 13 indexed citations
13.
Sugarman, Steven, Carolyn Wasserheit, Tiffany A. Troso-Sandoval, et al.. (2008). A pilot study of dose-dense adjuvant paclitaxel without growth factor support for women with early breast carcinoma. Breast Cancer Research and Treatment. 115(3). 609–612. 9 indexed citations
14.
Partridge, Ann H., Antonio C. Wolff, P. Kelly Marcom, et al.. (2008). The impact of sharing results of a randomized breast cancer clinical trial with study participants. Breast Cancer Research and Treatment. 115(1). 123–129. 22 indexed citations
15.
Lake, Diana & Clifford A. Hudis. (2004). High-Dose Chemotherapy in Breast Cancer. Drugs. 64(17). 1851–1860. 20 indexed citations
16.
Johnson, Elizabeth A., et al.. (2004). Phase II Trial of Vinorelbine Plus Doxorubicin in Relapsed Small-Cell Lung Cancer. American Journal of Clinical Oncology. 27(1). 19–23. 6 indexed citations
17.
Ahmed, Tauseef, R Kancherla, Zeeshan Qureshi, et al.. (2000). High-dose chemotherapy and stem cell transplantation for patients with stage IV breast cancer without clinically evident disease: correlation of CD34+ selection to clinical outcome. Bone Marrow Transplantation. 25(10). 1041–1045. 5 indexed citations
18.
Lake, Diana, et al.. (1996). Graft-versus-host disease: Possible higher risk for African American patients. Cancer. 78(7). 1492–1497. 13 indexed citations
19.
Lake, Diana, et al.. (1996). Graft‐versus‐host disease: Possible higher risk for African American patients. Cancer. 78(7). 1492–1497. 1 indexed citations
20.
Lake, Diana, et al.. (1996). Fluconazole versus Amphotericin B in the Treatment of Esophageal Candidiasis in Cancer Patients. Chemotherapy. 42(4). 308–314. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by А. Н. Махсон Breakdown of academic impact, for papers by Günther Steger Breakdown of academic impact, for papers by A. Antón Breakdown of academic impact, for papers by Evangelia Razis Breakdown of academic impact, for papers by Hans‐Joachim Lück Breakdown of academic impact, for papers by Thomas E. Seay Breakdown of academic impact, for papers by James D. Reimann Breakdown of academic impact, for papers by D. Fennelly Breakdown of academic impact, for papers by Vicente Guillém Breakdown of academic impact, for papers by Giovanna Masci
Rankless by CCL
2026